Your browser doesn't support javascript.
loading
Docosahexaenoic Acid Sensitizes Leukemia Lymphocytes to Barasertib and Everolimus by ROS-dependent Mechanism Without Affecting the Level of ROS and Viability of Normal Lymphocytes.
Zhelev, Zhivko; Ivanova, Donika; Lazarova, Desislava; Aoki, Ichio; Bakalova, Rumiana; Saga, Tsuneo.
Afiliação
  • Zhelev Z; Medical Faculty, Trakia University, Stara Zagora, Bulgaria Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Sofia, Bulgaria.
  • Ivanova D; Medical Faculty, Trakia University, Stara Zagora, Bulgaria.
  • Lazarova D; Medical Faculty, Sofia University "St. Kliment Ohridski", Sofia, Bulgaria.
  • Aoki I; Molecular Imaging Center, National Institute of Radiological Sciences, Inage-ku, Chiba, Japan.
  • Bakalova R; Medical Faculty, Sofia University "St. Kliment Ohridski", Sofia, Bulgaria Molecular Imaging Center, National Institute of Radiological Sciences, Inage-ku, Chiba, Japan bakalova@nirs.go.jp.
  • Saga T; Molecular Imaging Center, National Institute of Radiological Sciences, Inage-ku, Chiba, Japan.
Anticancer Res ; 36(4): 1673-82, 2016 Apr.
Article em En | MEDLINE | ID: mdl-27069145
Buscar no Google
Base de dados: MEDLINE Assunto principal: Linfócitos / Leucemia / Ácidos Docosa-Hexaenoicos / Antineoplásicos Idioma: En Revista: Anticancer Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Bulgária
Buscar no Google
Base de dados: MEDLINE Assunto principal: Linfócitos / Leucemia / Ácidos Docosa-Hexaenoicos / Antineoplásicos Idioma: En Revista: Anticancer Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Bulgária